Annals of Emergency Medicine
Volume 39, Issue 3 , Pages 258-267 , March 2002

Adverse drug events in emergency department patients

Presented in poster form at the Society for Academic Emergency Medicine annual meeting, Chicago, IL, May 1998 (Hafner J Jr, Bucheit K, Squillante M, et al. Adverse drug events in emergency department patients. Acad Emerg Med. 1998;5:528).

Received 26 March 2001 ,Revised 28 September 2001 ,Accepted 30 October 2001.

References 

  1. In:  Kohn LT,  Corrigan JM,  Donaldson M editor. To Err Is Human: Building a Safer Health System. Washington, DC: Institute of Medicine; 1999;
  2. Bates DW, Cullen DJ, Laird N, et al.  Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29–34
  3. Leape LL, Brennan TA, Laird N, et al.  The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377–384
  4. Classen DC, Pestotnik MS, Evans RS, et al.  Adverse drug events in hospitalized patients: excessive length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–306
  5. Thomas EJ, Studdert DM, Newhouse JP, et al.  Costs of medical injuries in Utah and Colorado. Inquiry. 1999;36:255–264
  6. Smith KM, McAdams JW, Frenia ML, et al.  Drug-related problems in emergency department patients. Am J Health Syst Pharm. 1997;54:295–298
  7. Karas S. The potential for drug interactions. Ann Emerg Med. 1981;10:627–630
  8. Beers MH, Storrie M, Lee G. Potential adverse drug interactions in the emergency room. An issue in the quality of care. Ann Intern Med. 1990;112:61–64
  9. Herr RD, Caravati EM, Tyler LS, et al.  Prospective evaluation of adverse drug interactions in the emergency department. Ann Emerg Med. 1992;21:1331–1336
  10. Prince BS, Goetz CM, Rihn TL, et al.  Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm. 1992;49:1696–1700
  11. Goldberg RM, Mabee J, Mammone M, et al.  A comparison of drug interaction software programs: applicability to the emergency department. Ann Emerg Med. 1994;24:619–625
  12. Goldberg RM, Mabee J, Chan L, et al.  Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14:447–450
  13. Raschetti R, Morgutti M, Menniti-Ippolito F, et al.  Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54:959–963
  14. Schneitman-McIntire O, Farnen TA, Gordon N, et al.  Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health Syst Pharm. 1996;53:1416–1422
  15. Stoukides CS, D'Agostino PR, Kaufman MB. Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm. 1993;50:712–714
  16. Aparasu RR. Drug-related-injury visits to hospital emergency departments. Am J Health Syst Pharm. 1998;55:1158–1161
  17. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health Syst Pharm. 1996;53:1422–1426
  18. Cullen DJ, Sweitzer BJ, Bates DW, et al.  Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25:1289–1297
  19. Bates DW, Spell N, Cullen DJ, et al.  The costs of adverse drug events in hospitalized patients. JAMA. 1997;277:307–311
  20. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized patients. J Gen Intern Med. 1993;8:289–294
  21. Naranjo CA, Busto U, Sellers EM, et al.  A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245
  22. Koch-Weser J. Definition and classification of adverse drug reactions. Drug Information Bull. 1968;2:72–78
  23. National Coordinating Council for Medication Error Reporting and Prevention . About medication errors. Available at www.nccmerp.orgJanuary 14, 2001; Accessed
  24. Bates DW, Boyle DL, Vander Vliet MB, et al.  Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199–205
  25. Witzig R. The medicalization of race: scientific legitimization of a flawed social construct. Ann Intern Med. 1996;125:675–679
  26. Public Health Service and Health Care Financing Administration . International Classification of Diseases, 9th Revision, Clinical Modification. Washington, DC: Public Health Service; 1991;
  27. Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol. 1977;11:75–78
  28. Lanctôt KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clin Pharmacol Ther. 1995;58:692–698
  29. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46
  30. Tango T. Equivalence test and confidence interval for the difference in proportions for the paired-sample design. Stat Med. 1998;17:891–908
  31. Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital: a 9-year experience. Arch Intern Med. 1997;157:1569–1576
  32. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277:312–317
  33. Nourjah P. National Hospital Ambulatory Medical Care Survey: 1997 Emergency Department Summary. Advance data from vital and health statistics; no. 304 Hyattsville, MD: National Center for Health Statistics; 1999;
  34. Carbonin P, Pahor M, Bernabei R, et al.  Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?. J Am Geriatr Soc. 1991;39:1093–1099
  35. Domecq C, Naranjo A, Ruiz I, et al.  Sex-related variations in the frequency and characteristics of adverse drug reactions. Int J Clin Pharmacol. 1980;18:362–366
  36. Hanlon JT, Schmader KE, Koronkowski MJ, et al.  Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45:945–948
  37. Nolan L, O'Malley K. Prescribing for the elderly, part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988;36:142–150
  38. Montamat SC, Cusak B. Overcoming problems with polypharmacy and drug misuse. Clin Geriatr Med. 1992;8:143–158
  39. Stewart RB, Cooper JW. Polypharmacy in the aged: practical solutions. Drugs Aging. 1994;4:449–461
  40. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy. 1996;16:701–707
  41. Bigby JA, Dunn J, Goldman L, et al.  Assessing the preventability of emergency hospital admissions: a method for evaluating the quality of medical care in a primary care facility. Am J Med. 1987;83:1031–1086
  42. Caranasos G, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalization. JAMA. 1974;228:713–717
  43. Hurwitz N, Wade OL. Factors predisposing to adverse drug reactions. BMJ. 1969;1:536–539
  44. Reinstein PF, Robinson JI. Annual adverse drug experience report: 1994. Rockville, MD: Division of Epidemiology and Surveillance, Food and Drug Administration, US Department of Health and Human Services; undated.
  45. Keith MR, Bellanger-McCleery RA, Fuchs JE. Multidisciplinary program for detecting and evaluating adverse drug reactions. Am J Hosp Pharm. 1989;46:1809–1818
  46. Classen DC, Pestotnik SL, Evans RS, et al.  Computerized surveillance of adverse drug events in hospitalized patients. JAMA. 1991;266:2847–2851
  47. Cullen DJ, Bates DJ, Small SD, et al.  The incident reporting system does not detect adverse drug events: a problem for quality improvement. J Qual Improvement. 1995;21:541–548
  48. Figueiras A, Tato F, Fontainas J, et al.  Influence of physicians' attitudes on reporting adverse drug events: a case-control study. Med Care. 1999;37:809–814
  49. United States General Accounting Office, Health, Education, and Human Services Division . GAO Report to Congressional Requesters. Washington, DC: United States General Accounting Office, Health, Education, and Human Services Division; 2000; Publication No. GAO/HEHS-00-21
  50. Burnum JF. Preventability of adverse drug reactions [letter]. Ann Intern Med. 1976;85:80–81

☆ Author contributions are provided at the end of this article.

☆☆ Address for reprints: John W. Hafner, Jr., MD, Department of Emergency Medicine, OSF Saint Francis Medical Center, 530 NE, Glen Oak Avenue, Peoria, IL 61637; 309-655-2553, fax 309-655-2602; mlhafner@home.com; jhafner@pol.net.

PII: S0196-0644(02)73527-0

doi: 10.1067/mem.2002.121401

Annals of Emergency Medicine
Volume 39, Issue 3 , Pages 258-267 , March 2002

Article Tools

* Image Usage & Resolution